secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001214659-24-000330
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro appoints founder Milton C. Ault III as Vice Chairman and director
--------------------------------------------------------------------------------

- Appointment effective January 4, 2024; Ault founded the company in 2016 and previously served as Chairman.
- Consulting agreement, including compensation, terminated upon appointment.
- Ault also serves as Executive Chairman of Ault Alliance, Inc. (NYSE American) and Chairman of Ault Disruptive Technologies Corp. (NYSE).
- Compensation will follow the company's standard board compensation policies as disclosed in FY2023 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465924000330/0001214659-24-000330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465924000330/o152408k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-24-000330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer